drugset / Trial / NCT05001152

Taste Assessment of Ozanimod

NCT05001152

Phase 1 Completed 7 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.

Timeline

Start
2021-09-09
Primary completion
2021-09-17
Completion
2021-09-27

Drugs

EvaluationDrugModalityDoseRoute
Background Ozanimod Small molecule

Indications

No indication recorded.